Project Φ.X Strategic Briefs

2025.03.27 Φ.X_Vol01 Mastering LOE Maximization & Planning
 

Φ.X_Vol01 Mastering LOE Maximization & Planning [2025.03.27]

Explore insights into effectively managing Loss of Exclusivity (LOE) in biopharma through strategic foresight and intelligence.

Φ.X_Vol04_Anticipating the Unseen
 

Φ.X_Vol02_Navigating AI v1.0 [03.21.2025]

Navigating the convergence of AI and Biopharma.

Φ.X_Vol03_Protein Degradation

Φ.X_Vol03_Protein Degradation

Inside the $20B+ Battle for protein control.

Φ.X_Vol04_Anticipating the Unseen v1.0 [03.24.2025]

Φ.X_Vol04_Anticipating the Unseen v1.0 [03.24.2025]

How humint detects strategic market shifts before the market can react.

Φ.X_Vol05_Checkpoint Collapse Rebuilding Value in IO v1.0 [03.24.2025]

Φ.X_Vol05_Checkpoint Collapse Rebuilding Value in IO v1.0 [03.24.2025]

Rebuilding value in IO.

Φ.X_Vol06_Project Φ Breakpoint 2025

Φ.X_Vol06_Project Φ Breakpoint 2025

Strategic Dislocation and the Remapping of Global Biopharma-vFULLProject.

Φ.X_Vol07_Strategic Brief HUMINT-Hallucination v1.0 [04.08.2025]

Φ.X_Vol07_Strategic Brief HUMINT-Hallucination v1.0 [04.08.2025]

Why the Future of Biopharma Strategy Depends on People not just Plataforms.

Φ.X_Vol08_Project Φ The Rescripting of Biopharma’s Supply Chain v1.0 [04.08.2025].

Φ.X_Vol08_Project Φ The Rescripting of Biopharma’s Supply Chain v1.0 [04.08.2025].

Strategic Intelligence Briefing.

Φ.X_Vol08_Project Φ The Rescripting of Biopharma’s Supply Chain v1.0 [04.08.2025].

Φ.X_Vol09_Project Φ Geopolitical Fault Lines in Biopharma BD.

Reshoring, Resilience and Strategic Partnerships.

Φ.X_Vol10_Project Φ Omnichannel V1 [04.15.2025].

Φ.X_Vol10_Project Φ Omnichannel V1 [04.15.2025].

This Report Exposes the Disconnect and Redefines the Commercial Metrics Biopharma Should Measure Next.

Φ.X_Vol11_PhiX Never 2025 V1 [04.21.2025].

Φ.X_Vol11_PhiX Never 2025 V1 [04.21.2025].

Everything you Needed to Know Before the Deal Went Sideways.

Φ.X_Vol12_PhiX Tarrifs [05.01.2025].

Φ.X_Vol12_PhiX Tarrifs [05.01.2025].

A Project Φ.X Strategic Black Paper on Post-April 2025 Tariff Policy and Global Pharma Dislocation.

Φ.X_Vol13_PhiX The Coming Stealth Market [05.06.2025].

Φ.X_Vol13_PhiX The Coming Stealth Market [05.06.2025].

Privete Equity, Radiopharma, and the Rise of Biopharma-Edge Microblocs.

Φ.X_Vol14_PhiX IRA [05.02.2025].

Φ.X_Vol14_PhiX IRA [05.02.2025].

Six Quarters to Peak or Bust.